Drug Shortages Advocacy

Senate Homeland Security Report Incorporates ASHP Recommendations to Address Drug Shortages

Published: March 23, 2023

The Senate Committee on Homeland Security & Governmental Affairs held a hearing on the causes of drug shortages along with the health and national security issues they raise. The committee heard testimony from experts, including ASHP member Erin Fox from the University of Utah. Witnesses noted the need for greater transparency into drug supply chains to inform health-system purchasing and the Food and Drug Administration’s response to shortages.

The committee also issued a report entitled Short Supply: The Health and National Security Risks of Drug Shortages. ASHP has worked closely with the committee to raise awareness of drug supply chain vulnerabilities. The committee’s report incorporates recommendations that ASHP has made to address national security risks in the drug supply chain and improve supply chain transparency and resilience.


Posted March 23, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information